Back to DE D. E. Shaw & Co., Inc.

AVIRAVIR
20 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ATEA PHARMACEUTICALS INC

D. E. Shaw & Co., Inc. holds 345,186 shares of AVIR (ATEA PHARMACEUTICALS INC), worth $1.6M as of 2026-Q2. The position was decreased (-9.0% shares). AVIR represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$1.6M

Current Shares

345,186

Total Value Change

-$135,885

Total Shares Change

+316,999

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
345,186
-9.0%
$1.6M0.0%$4.65
0
2026-Q1
Decreased
379,314
-18.4%
$2M0.0%$4.82
0
2025-Q4
Increased
464,787
+27.4%
$1.7M0.0%$3.55
32
2025-Q3
Increased
364,768
+86.3%
$1.1M0.0%$2.92
39
2025-Q2
Decreased
195,852
-43.2%
$705,0670.0%$3.45
0
2025-Q1
Increased
344,545
+34.5%
$1M0.0%$2.93
32
2024-Q4
Increased
256,083
+32.3%
$857,8780.0%$3.33
32
2024-Q3
Increased
193,578
+30.9%
$648,4860.0%$3.44
31
2024-Q2
Decreased
147,913
-28.8%
$489,5920.0%$3.31
0
2024-Q1
Increased
207,759
+12.2%
$839,3460.0%$4.04
28
2023-Q4
Increased
185,177
+164.7%
$564,7900.0%$3.05
39
2023-Q3
Decreased
69,949
-16.1%
$209,8470.0%$3.00
0
2023-Q2
Increased
83,422
+67.9%
$311,9980.0%$3.75
35
2023-Q1
Increased
49,698
+23.6%
$166,4880.0%$3.27
27
2022-Q4
Increased
40,222
+38.0%
$193,4680.0%$4.81
30
2022-Q3
New
29,157
-
$166,0000.0%$5.60
31
2022-Q1
Exited
0
-100.0%
$00.0%$7.08
0
2021-Q4
New
19,404
-
$173,0000.0%$9.05
31
2021-Q2
Exited
0
-100.0%
$00.0%$24.41
0
2021-Q1
New
28,187
-
$1.7M0.0%$56.23
36

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used